ELV logo

Elevance Health Inc. (ELV)

$359.07

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ELV

Market cap

$79.80B

EPS

24.53

P/E ratio

14.6

Price to sales

0.41

Dividend yield

1.905%

Beta

0.522789

Price on ELV

Previous close

$360.22

Today's open

$360.43

Day's range

$357.88 - $363.42

52 week range

$273.71 - $458.75

Profile about ELV

CEO

Gail K. Boudreaux

Employees

104200

Headquarters

Indianapolis, IN

Exchange

New York Stock Exchange

Shares outstanding

222238763

Issue type

Common Stock

ELV industries and sectors

Healthcare

Medical Service Plans

News on ELV

AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) [NYSE: ELV], as well as most of its non-Blue-branded subsidiaries. In addition, AM Best has upgraded the FSR to A (Excellent) from A- (Excellent) and the Long-Term ICR to “a+” (Excellent).

news source

Business Wire • Dec 12, 2025

news preview

Elevance Health Reflects On The Changed Role of Health Plans

INDIANAPOLIS--(BUSINESS WIRE)--As 2025 draws to a close, Elevance Health highlights how today's health plans are evolving to better support their members in a broader range of situations that affect health, including cancer diagnoses, mental health crises, and unexpected health concerns during pregnancy. From employer-sponsored health insurance to government-sponsored programs, health plans are evolving to better support their members in a broader range of situations that affect health. In part.

news source

Business Wire • Dec 12, 2025

news preview

Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises. This appointment reflects Elevance Health's ongoing bo.

news source

Business Wire • Dec 10, 2025

news preview

Anthem Blue Cross and Blue Shield Donates Over $60,000 to Support Holiday Food Distributions Across New York

NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield of New York today announced a donation of more than $60,000 to help fund more than 32 food distribution events in partnership with The Campaign Against Hunger (TCAH) and Food Bank for New York City. The initiative will provide an added lifeline to families struggling to make ends meet, especially during the holiday season when budgets are stretched and demand for food assistance rises.

news source

Business Wire • Dec 8, 2025

news preview

Impax U.S. Sustainable Economy Fund Q3 2025 Contributors And Detractors

Intel (INTC) rallied strongly in September as the company announced a partnership with Nvidia on integrating Intel's x86 central processing units (CPUs) with Nvidia GPUs in AI server systems. Oracle (ORCL) (Information Technology, Systems Software) performed strongly on the continued follow-through following strong quarterly results. Elevance Health (ELV) (Health Care, Managed Health Care) has a high Corporate Resilience Score and is aligned to the Health Access and Innovation theme.

news source

Seeking Alpha • Dec 8, 2025

news preview

Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health announced today that it expanded access of its Virtual Assistant, a digital experience designed to help members easily access information, understand their benefits, and find care with confidence. Available through the Sydney Health app and Elevance Health–affiliated health plan websites, Virtual Assistant uses conversational technology to simplify healthcare navigation and improve engagement between members and their health plans. “At Elevance Hea.

news source

Business Wire • Dec 5, 2025

news preview

Elevance Health: The Potential Turnaround The Market Isn't Pricing In

Elevance Health is rated a Buy with a $400 price target, reflecting 18% upside and potential market outperformance. ELV trades at a significant discount to peers, with an 11x earnings multiple and strong double-digit top-line growth despite sector headwinds. Recent FQ3 2025 results showed a double-beat, with revenue up 12% year-over-year and EPS surpassing analyst estimates, signaling a turnaround.

news source

Seeking Alpha • Dec 2, 2025

news preview

Artisan Select Equity Fund Q3 2025 Portfolio Review

Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung shares are finally starting to benefit from AI enthusiasm. Elevance's share price declined by 16%, making it our largest negative contributor.

news source

Seeking Alpha • Nov 27, 2025

news preview

Health Insurers Stocks Reflect Obamacare Subsidy Deal Can Be Reached

Health insurance company stocks rose again Wednesday before the Thanksgiving holiday amid hope the Trump administration and Congress can agree on an extension of tax credits for those who buy individual coverage under the Affordable Care Act.

news source

Forbes • Nov 26, 2025

news preview

First Eagle Global Equity ETF Q3 2025 Portfolio Update

Global Equity ETF posted a return of 1.80% in the third quarter of 2025. Leading contributors in the First Eagle Global Equity ETF this quarter included Oracle, Alphabet Inc. Class C, Samsung Electronics Co Ltd Pfd Non-Voting, Barrick Mining and Newmont Corporation. The leading detractors in the quarter were Elevance Health, Philip Morris, Shimano, Comcast Corporation Class A and Salesforce.

news source

Seeking Alpha • Nov 25, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Elevance Health Inc.

Open an M1 investment account to buy and sell Elevance Health Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ELV on M1